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Abstract
Background
According to the most recent CDC statistics, the influenza virus kills between 12,000 and 56,000
people per year in the United States. Although influenza vaccination is recommended each year,
only about half of all Americans are actually receiving the vaccine annually. The goal of this
quality improvement project was to increase influenza vaccination rates at a large academic
medical center in Kentucky. At baseline, there was no standardized screening protocol in place
prior to this study.
Methods
This study implemented a pre-test post-test design to evaluate the impact of a process change
intervention on vaccination status from September 1, 2017 to February 28, 2018. Participants for
this study were taken from the list of all patients currently active at this clinic via the electronic
medical record. This study was conducted in four phases, using the Plan Do Study Act (PDSA)
improvement model as a guide. Focus groups were held with clinic staff to establish a process
change for influenza vaccination. Chart audits were done monthly and changes were made based
on feedback from clinic staff and vaccination rates.
Results
Starting vaccination rates at the clinic were 0.65% in October 2017. The first full month of entire
clinic compliance with the standardized process was February 1, 2018 to February 28, 2018, with
vaccination rates of 30.42%. This was a 29.77% increase in vaccination rates during the study
and a 5.2% increase from the 2016-2017 influenza vaccination rates of 25%.
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Conclusion
Through a team based practice improvement process, overall vaccination rates increased at this
clinic. MACRA reimbursement requirements were achieved at this clinic due to this vaccination
increase. Creating a standardized screening and vaccination protocol was feasible and effective
in increasing vaccination rates within this clinic.
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Background
The influenza virus is estimated to kill between 12,000-56,000 people each year in the
United States (CDC, 2017). There are between 9.2 and 36 million cases of influenza in the U.S.
each year, and between 140,000-710,000 influenza-related hospitalizations (CDC, 2017).
Although exact numbers of influenza deaths, hospitalizations, and cases are difficult to obtain
each year due to the mass numbers, comorbidities leading to influenza-associated deaths, and
missed testing opportunities, the CDC (2018) uses mortality data obtained from the National
Center for Health Statistics to estimate annual influenza death rates.
The burden of the influenza virus in the U.S. typically falls from the beginning of
October through the end of March, with peak activity in December, January, and February
(CDC, 2018). Influenza activity has been reported through the month of May in previous
influenza seasons. Since the 2017-2018 influenza season is on track to be one of the worst
according to the CDC, vaccination is crucial for prevention of falling ill with the influenza virus.
While there are other important ways to prevent the influenza virus such as handwashing
and avoiding contact with those who are sick, the most effective strategy for preventing the virus
is vaccination (CDC, 2017). The CDC recommends all people aged six months and older receive
the influenza vaccination as the single best way to prevent illness (CDC, 2017). Those who
cannot receive the influenza vaccine include those younger than six months and those who have
life-threatening allergies to the vaccine. Vaccination is especially important in those at high risk
for serious complications from the virus such as children, those who are pregnant or trying to
become pregnant, those 65 and older, and people with underlying chronic conditions (CDC,
2017). The influenza virus can be deadly in these populations.
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The influenza vaccination protects against three or four different strains of the virus,
depending on the vaccination components. While the influenza vaccination has not been
especially effective for the 2017-2018 influenza season, the CDC still stresses the importance of
the influenza vaccine, as it has been shown to decrease the likelihood of hospitalizations and
deaths from the virus (CDC, 2017). Rates of hospitalizations from the influenza virus are the
highest on record since 2010, when the CDC began to track hospitalization rates related to
influenza (CDC, 2017). Not only does receiving the influenza vaccine decrease chances of
catching the virus, but it also has been shown to decrease severity and duration of symptoms
(CDC, 2017). Decreasing the severity and duration of symptoms then leads to an overall
decrease in hospitalizations and deaths from the virus.
Although the CDC recommends influenza vaccination each year, in the 2016 National
Health Interview Survey, only 49.9% of those aged 6 months to 17 years, 31.8% of those aged
18-49, 45.2% of those aged 50-64, and 67.2% of those aged 65 and over reported receiving the
vaccine in the past twelve months (Clarke, Norris, & Schiller, 2016). This totals to only 48.53%
of all Americans receiving the influenza vaccination during the past year. Coverage of the spread
of the influenza virus is rampant on most large news stations, as well as on social media.
However, despite community knowledge of the rising hospitalizations and deaths from the
influenza virus, as well as provider recommendation, vaccination rates continue to be low.
Local Problem
Kentucky ranks 9th in death rates for influenza and pneumonia in the United States, with
a death rate of 19.3% (CDC, 2015). Influenza and pneumonia are tied as the 9th leading causes of
death in Kentucky (CDC, 2015). For the 2017-2018 influenza season, Kentucky is included in
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the widespread influenza activity currently taking place in the United States, with increasing
cases, hospitalizations, and deaths on a daily basis (CDC, 2017).
Kentucky has a 42.6% total reported influenza vaccination rate, which falls below the
national average of 48.5% (U.S. Department of Health and Human Services, 2018). Fayette
County has a slightly higher vaccination rate of 54.76% (U.S. Department of Health and Human
Services, 2018). Kentucky’s low vaccination rates represent a disparity and are attributed to the
previously mentioned barriers, in addition to access to care and affordability of care (CDC,
2017).
The clinic in which this study took place is one of seventeen family medicine clinics
associated with this large academic center in Kentucky. Prior to initiation of this study, this clinic
was not meeting MACRA reimbursement requirements for influenza vaccination administration.
Vaccination rates at this clinic were 25% for the 2016-2017 influenza season. This low
vaccination rate not only decreased the quality of care received in the clinic, but impacted the
entire medical center financially. Without increased compliance for vaccination rates, this large
academic center could lose up to four million dollars in 2019 from penalties from MACRA.
Barriers to Vaccination
This low vaccination rate can be attributed to a number of barriers such as a fear of side
effects, moral or religious objections, limited access to care, and lack of knowledge about the
vaccine (Ventola, 2016). According to a focus group with staff at this clinic, there are three main
barriers to vaccination: lack of patient belief in the effectiveness of the vaccine, low staff
enthusiasm about the vaccine, and patient misconceptions about the vaccine.
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One of the most common barriers to being vaccinated is the misconception that one can
catch the influenza virus from the influenza vaccine (Ventola, 2016). This is especially common
among the young adult population. In a study of college students, Benjamin and Bahr (2016)
found that nearly 50% of participants believed they would get influenza from receiving the
vaccine. This barrier can be overcome through patient education regarding the difference
between a potential immune response from the vaccine and actually being ill with the influenza
virus (Ventola, 2016).
Another barrier to vaccination is the patient’s belief in the effectiveness of the influenza
vaccine. With the CDC estimating 30%-60% effectiveness for the vaccine available for this
2017-2018 influenza season, many patients feel that there is no point in receiving the vaccine
(CDC, 2017). Again, this barrier can be overcome through patient education on the
recommendations for the vaccine, despite its overall effectiveness during any given season.
Emphasis needs to be placed on the fact that although the vaccine is only 30-60% effective,
healthy people are dying and no one truly knows how they will respond to the virus.
The final barrier to vaccination and the barrier that this quality improvement project
focused on is clinic staff enthusiasm and compliance in screening for and recommending the
vaccine. Overcoming this barrier was identified by clinic staff as one of the best ways to improve
vaccination compliance within the clinic. The overall vaccination rate for the 2016-2017
influenza season at this clinic was 25%. This lack of screening and recommendation often stems
from a lack of a standardized process, forgetfulness, and increased workflow (Pennant et al.,
2015). Through a standardized vaccination screening and administration process, this barrier can
be overcome (Ventola, 2016).
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Purpose
The purpose of this quality improvement project was to improve the process of
vaccination administration and to increase vaccination rates at a large academic medical center in
Kentucky. By implementing a vaccination screening program beginning October 2017,
vaccination rates were expected to increase by March 2018. Specific aims of this study were:
1. Evaluate the impact of implementing a vaccination screening program on vaccination rates.
GOAL: Increase vaccination rates at this clinic to 60% by March 2018.
2. Evaluate the impact of a team based practice improvement process to increase vaccination
documentation.
GOAL: Increase documentation of outside receipt of vaccine or vaccination refusal for this clinic
to 60% by March 2018.
Methods
Context
This study implemented a pre-test post-test design to evaluate the impact of a process
change intervention on vaccination status.
Setting
This study took place at a large academic medical center in Kentucky. This clinic is one
of seventeen clinics in association with this academic center and with approximately thirty
providers, aims to serve a population with diverse needs. IRB approval was obtained prior to
initiation of this study.
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Sample
Participants for this study were selected from family medicine patients at this clinic. All
patients were included as participants regardless of gender, age, vaccination status, or allergies.
There was no exclusion of patients based on eligibility for the vaccine or if they were seen at the
clinic during the time period of this study. The list of patients with documented influenza
vaccination was obtained via the clinic’s electronic medical record. This data was obtained from
monthly chart audits of all patients registered as part of the family medicine clinic. The
compliance rate was obtained by dividing the patients who received the vaccine by all patients in
the family medicine clinic x 100. There was no incentive for participants to take part in this
research study.
Interventions
This study was conducted in four phases. Using the PDSA model as a guide, focus
groups were held with clinic staff. The PDSA model is an improvement model that consists of
planning, doing, studying, and then acting on the results (Institute for Healthcare Improvement,
2018). Chart audits were done monthly and changes were made based on feedback from clinic
staff and vaccination rates.
The team involved in the implementation of this quality improvement project included all
physicians, nurse practitioners, nurses, and CSTs working at this clinic. Clinical Services
Technicians (CSTs) are a part of the healthcare team at this clinic and are responsible for the
administration of vaccinations. A go-see was completed with CSTs from the red, purple, and
green teams in September 2017 to assess the current vaccination process at the clinic. A go-see
was an observation day to assess the CSTs normal workflow. CSTs in this clinic are divided into
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teams which allow for even distribution between providers. A go-see included observing
multiple CSTs as they checked the patient in and assessing their process during an entire shift.
After this original go-see, a current process map was created (See Figure 1). Areas for
improvement were then identified as a group and a plan for the first PDSA was made.
Figure 1
Current Process Flow
-height/weight
Pt arrives

Ready for provider

-medications
-vital signs

Baseline/Current State
There was no standardized process of vaccination screening at this clinic prior to this
intervention. After calling the patient from the lobby, CSTs would obtain chief complaint,
height, weight, vital signs, allergies, and an accurate medication list. Prior to implementation of
this standardized process, immunization screening was only done if there was time and/or if the
CST remembered.
Prior to the start of this quality improvement project, CSTs had no common process for
immunization screenings and were screening based on personal preference and time per patient.
This information was obtained via word of mouth from CSTs on the green, red, and purple teams
at this clinic. There was not common knowledge regarding documentation of outside receipt of
influenza vaccination or vaccine refusal.
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PDSA Cycle 1
A meeting was then held in September 2017 with CSTs from the green team and a new
process flow map was developed after identifying areas for improvement. The green team was
chosen initially to test this intervention on a small scale prior to spreading it to the entire clinic
until the process was perfected. Starting on a small scale prior to initiation to the entire clinic
allowed for a changes to be made as barriers were identified. This new process flow map was
developed and included a clear process for vaccination screening and administration agreed upon
by both CSTs and providers on the green team. The CSTs would screen for vaccination status
immediately prior to leaving the room during the patient encounter. A follow-up was then done
weekly to assess for recommendations for improvements. A second go-see was done in October
2017 with the green team CSTs to assess flow and compliance.
PDSA Cycle 2
The process was evaluated through monthly chart audits of immunization status for the
clinic and a process meeting with the CSTs. During the go-see in October 2017, a limitation to
documentation was identified. CSTs were not able to document refusal of vaccination in the
immunization record; only providers had this capability. This was then brought up with the
information technology department, but they were not able to resolve the problem during the
time frame of this study. The information technology department is currently in the process of
working on a way for CSTs to document refusal of the vaccination. A new process flow map was
then created, which included communication between CSTs and providers in documentation of
refusal of the vaccine. This communication was done via a face to face transaction. The provider
when then document this refusal in their note. Utilizing a new PDSA cycle, this new process
flow was rolled out on the green team on October 31, 2017.
10
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Using this new process, CSTs at this clinic assessed immunization status at the end of
their patient interaction, prior to provider evaluation of the patient. This new standardized
protocol then allowed for higher compliance of immunization screening and ability for CSTs to
vaccinate the patient prior to provider evaluation. Data on vaccination rates were then collected
via chart audits from November 1, 2017 to November 30, 2017.
PDSA Cycle 3
After the chart audit in November 2017, a new process flow map was developed based on
feedback from the CSTs regarding a barrier to documentation of outside receipt of the influenza
vaccination. A new process was developed to address this barrier to documentation. CSTs would
document this outside receipt of the vaccination while they were still in the room with the patient
to ensure completion, rather than waiting until they had left the room or solely communicating
this to the provider. This would be documented in the immunization chart in the exact same spot
as before, but they would click a box detailing “document without ordering.” This would then
allow for CSTs to document where and when a patient received the vaccine outside of this
facility. Another chart audit was then obtained from December 1, 2017 to December 31, 2017,
assessing for influenza vaccination compliance.
This final process flow map was then ready to be distributed to the entire clinic on
January 24, 2018 (See Figure 2). The map was distributed to the entire clinic via an educational
meeting and PowerPoint presentation describing the process flow and assessing for potential
barriers and areas for improvement. No potential barriers or areas for improvement were
identified during this meeting. A focus group discussion was held with the CSTs to discuss the
process. It was agreed upon by the entire family medicine team to implement this process and
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then continue with regular chart audits to assess the effectiveness of this process. Chart audits
were then conducted monthly on vaccination rates until February 28, 2018.
Figure 2
New Process Flow

Measures (see Table 1): The measures for this study were:
1. Demographics: Age in years, gender, ethnicity, and vaccination status of patients were
obtained from the patient charts
2. Vaccination rates: Vaccination rates were based on clinic staff documentation of providing a
vaccination to patients within the specified time. There was only one allotted spot for
immunization documentation in the electronic medical record. Individuals receiving the
vaccination were coded as ‘1’ and those not receiving the vaccination were coded as ‘0’. A
ratio of those receiving vaccinations were calculated by dividing the number of those who
received vaccinations over the eligible population times 100.
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Table 1.
Study Measures
Measures

Description

Age
Gender

Age in years
Male vs Female

Ethnicity

White, Black,
Nominal
Hispanic, Indian,
Native American,
Mixed Race, Middle
Easter, Asian, Other
Diagnosis made by
Nominal
primary care
provider
Number who
Interval/ratio
received
vaccinations/number
eligible X 100

Active
Problem
Vaccination
Rates

Level of
Measurement
Interval/Ratio
Nominal

Analysis

Data Source

Means(SD), t-tests
Frequencies (%),
Chi-Square
Frequencies (%),
Chi-Square

Medical Records
Medical Records

Frequencies (%),
Chi-Square

Medical Records

Independent sample
t-test

Medical Records

Medical Records

Analysis
Vaccination rates at this clinic were obtained from monthly chart audits utilizing the
electronic medical record. Rates were described in percentages based on the number of patients
established in the family medicine clinic vs the number of patients whose current influenza
immunization status was documented. This study was not able to discriminate between who was
eligible for the influenza vaccination vs who was not eligible during these chart audits. This
uncontrollable data included immunocompromised patients and patients with allergies to the
vaccine who would have a contraindication to the vaccine.
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Results
PDSA Cycle 1
Continuous cycles of change were completed to improve vaccination rates. New cycles
were initiated based on feedback from clinic staff and vaccination rates. Baseline data for this
quality improvement project were obtained October 2017 after initiation of the standardized
protocol on the green team. Beginning influenza vaccination rates at this clinic were 0.65%.
PDSA Cycle 2
During the go-see in the middle of October 2017, a limitation to documentation was
identified. A second PDSA cycle was initiated, adding the verbal communication between CSTs
and providers of patient refusal of the influenza vaccine. The new process flow map was rolled
out to the green team on October 31, 2017. Data on vaccination rates were then collected from
the green team via chart audits from November 1, 2017 to November 30, 2017. Vaccination rates
at this time increased to 12.4%.
PDSA Cycle 3
Based on feedback obtained from the green team CSTs, a new process flow map was
created in November 2017. This new flow map included documentation of outside receipt of the
vaccine while the CST was still in the room with the patient. This outside receipt of the vaccine
was charted in the same place that they would chart administration of the vaccine. A second
chart audit was obtained from this same medical team from December 1, 2017 to December 31,
2017. Vaccination rates increased to 25.74% during this time.
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The final process flow map was implemented in the entire clinic on January 23, 2018 and
immunization rates for January 1, 2018 to January 31, 2018 were 30.03%. The first full month of
entire clinic compliance with standardized process began February 1, 2018. Immunization rates
for February 1, 2018 to February 28, 2018 were 30.42%. (See Figure 3) Immunization rates were
then compared to the same time period from the previous year.
Figure 3
Immunization Rates

Vaccination Rates 2017-2018 Influenza Season
February 1-28
January 1-31
December 1-31
November 1-30

October 1-31
0

5

10

15

20

25

30

35

Discussion
Through a team based practice improvement process, overall vaccination rates increased
in this primary care clinic. Comparison of the 2016-2017 to the 2017-2018 vaccination rates
showed a 5.2% increase after initiation of this standardized protocol. This percentage was
determined to be statistically significant through a chi-square test where the p-value <0.001.
Creating a standardized screening and vaccination protocol was feasible and effective in
increasing vaccination rates within this clinic.
Similar quality improvement projects have been published and also suggest an increase in
vaccination rates based on changing clinic procedures and recommendations (Stone, 2002 and
Parker et al, 2013). With a change in clinic procedures and recommendations, vaccination rates
15
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increased as a result. In a meta-analysis of 108 articles related to prevention strategies,
interventions such as organizational change of clinic procedures proved to be the best ways to
increase vaccinations and screenings (Stone, 2002). In a quality improvement project by Parker
et al. (2013), vaccination compliance was increased over a ten week period through the use of a
screening questionnaire and process change for HPV vaccination. Vaccination rates can be
increased significantly through process change utilizing an improvement model such as the
PDSA and data evaluation.
As a part of continuing quality improvement, this clinic has adopted this screening
protocol as standard procedure and will continue to use this influenza vaccination screening
process. This screening process can also be used in the future for other recommended vaccines.
This process can be improved through the use of automatic electronic medical record reminders
regarding overdue vaccinations in the patient’s chart. These automated reminders are currently
being developed by the information technology work group at this clinic.
Resistance to change was evident while observing CST compliance with the process
change. The CSTs did not think that they would have the time to initiate this screening protocol
into their busy schedule. Utilizing Prosci’s Best Practices in Change Management (2018), this
resistance to change was anticipated and we were proactive in managing the resistance. We used
Lewin’s change theory to combat this resistance and prepare CSTs for this change (Petiprin,
2016; See Figure 4). Education was provided to the CSTs on how long the process would take
and how it could best be integrated into their busy schedules. Although there was major
resistance in the beginning, this was overcome once CSTs realized this change could easily fit
into their schedules. The CSTs were also involved in identifying barriers to the process and
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changing the process as necessary. Although there was an attempt to overcome this barrier,
resistance to change could have been a factor in the overall vaccination results.
Figure 4
Lewin’s Change Theory

Limitations
A limitation identified in this study was the lack of ability of the CSTs to document
vaccination refusal in the electronic medical record. Although the information technology work
group is currently addressing this issue, they were not able to resolve it during the study. This
inability to document refusal led to an overall decrease in the vaccination percentages, as the
number of patients who refused should have been taken out of the number of patients eligible for
the vaccination. There was no way to establish eligibility and account for this via vaccination
rates in this study.
One factor that contributed to the increase in influenza vaccination during this study is
the commonality of vaccination rates increasing as the influenza season progresses. It was
expected that our beginning number would be low and that this number would rise throughout
17
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the influenza season, despite intervention. Although this could have been a contributing factor, it
is clear that intervention played a strong role in increasing these rates as there was a 5.2%
increase in vaccination rates from the 2016-2017 influenza season.
Practice Recommendations
While there was a significant increase in vaccination rates from the 2016-2017 influenza
season, overall clinic and enterprise goal of obtaining 60% vaccination rates for the 2017-2018
influenza season was not met during this study. It is projected that this goal could eventually be
met by continually educating patients on the importance of the influenza vaccine and ensuring
healthcare staff compliance with the vaccination process. Special influenza vaccine clinics could
be held prior to the start of the influenza season at the clinic to increase initial rates. This special
influenza vaccine clinic could be a way to reach patients who would not otherwise have a visit
during the influenza season. Vaccination rates should still be monitored for the upcoming
influenza seasons. This process can also be applied to all other vaccination rates. In order to
apply this successfully to other vaccination rates, patient eligibility would have to be previously
established in the electronic medical record.
It is also recommended that the inability to document refusal of the vaccine by CSTs be
resolved by the information technology work group. If CSTs have the ability to document refusal
of the vaccine, this will increase clinic compliance rates with vaccination percentages by taking
away from those eligible for the vaccine. This increase in clinic compliance with vaccine
administration will then aid in MACRA reimbursement for the entire academic medical center.
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Practice Implications
This increase in influenza vaccination rates will improve quality of care within this clinic.
Patients will have a decreased risk of becoming ill with the influenza virus, thus decreasing their
risk for hospitalizations and death from the virus. This increase in vaccination rates will improve
both patient quality of care and patient health outcomes.
Additionally, increasing the influenza vaccination rates will also help this clinic achieve
Medicare Access and CHIP Reauthorization Act (MACRA) requirements for reimbursement.
Through a standardized process of documentation, immunization data are able to be captured for
MACRA reimbursement. With electronic medical record changes allowing for documentation of
refusal of the vaccine, the clinic will be able to also use these refusals for MACRA
reimbursement. This increase in vaccination rates will also allow this clinic to maintain their
Patient Centered Medical Home (PCMH) accreditation.
Conclusion
The initiation of a standardized vaccination screening and administration protocol
increased vaccination rates at this clinic. Through the continued use of this standardized
vaccination process, influenza vaccination rates are expected to continue to rise for upcoming
influenza seasons. Although this project was effective, there is more work to be done to continue
to increase vaccination rates in the future and meet the goal of a 60% influenza vaccination rate
at this clinic.
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